5/18/2006 | BKBTCV | S&P: SFBC International still on watch
|
5/11/2006 | BKBTCV | S&P puts SFBC on negative watch
|
4/28/2006 | BKBTCV | S&P cuts SFBC outlook to negative
|
4/11/2006 | BKBTCVDD | Moody's downgrades SFBC
|
1/5/2006 | BKBTCV | Moody's may cut SFBC
|
12/22/2005 | CV | Market Commentary: Cephalon convertibles gain on patent agreement; SFBC up on possible sale; Albertson's, Placer lose
|
12/15/2005 | BKBTCV | S&P drops SFBC view to stable
|
11/21/2005 | CV | Market Commentary: GM mixed in light trade, Ford flat, Incyte gains on Pfizer pact, but SFBC falls
|
11/3/2005 | CV | Market Commentary: Chesapeake, Qwest trade higher; Abgenix, Amgen rise, but ImClone lower; SFBC plunges
|
6/13/2005 | BKBTCV | Moody's affirms SFBC
|
6/10/2005 | BKCV | S&P rates SFBC revolver B+
|
12/7/2004 | BKCV | S&P rates SFBC converts B-
|
12/2/2004 | BKCV | Moody's rates SFBC loans B2
|
9/9/2004 | CV | SFBC greenshoe exercised, raising convertibles to $143.75 million
|
8/6/2004 | CV | New Issue: SFBC upsized $125 million convertible yields 2.25%, up 35%
|
8/6/2004 | CV | Market Commentary: SFBC hits high mark of 104.125, while other new paper off a tad; GM, Ford pressured; Delta dives
|
8/5/2004 | CV | Market Commentary: SFBC bid up 1.25 points in gray; Goodyear earnings push up bonds; Schering-Plough, new issues gain
|
8/5/2004 | CV | Market Commentary: SFBC bid up 1.25 points in gray; Goodyear earnings push up bonds; Schering-Plough, new issues gain
|
8/3/2004 | CV | Market Commentary: Ford, GM converts slip on sales; Delta off but in holding pattern; Novell retreats; two deals emerge
|
8/3/2004 | CV | SFBC $100 million convertible talked at 2.25%-2.75% yield, up 30%-35%
|